Fisher E R, Redmond C K, Liu H, Rockette H, Fisher B
Cancer. 1980 Jan 15;45(2):349-53. doi: 10.1002/1097-0142(19800115)45:2<349::aid-cncr2820450226>3.0.co;2-p.
Estrogen receptor (ER) status was correlated with a large number of pathological and clinical characteristics of 178 invasive breast cancers. Positive ER was found to be significantly associated with high nuclear and low histologic grades, absence of tumor necrosis, presence of marked tumor elastosis, and older patients. These pathologic parameters enumerated are either directly or indirectly related to tumor differentiation suggesting that ER represents another index of this latter. Multivariate analyses disclosed that both age and tumor differentiation are associated with the ER status. Well-differentiated tumors were more frequently ER+ in older women. Inclusion of an estimate of tumor necrosis as well as patient age appears to allow for further discrimination of ER status in poorly differentiated lesions. Considerations relative to ER and tumor differentiation provide a possible explanation for the dichotomy of response to adjuvant chemotherapy observed in pre and postmenopausal women.
雌激素受体(ER)状态与178例浸润性乳腺癌的大量病理和临床特征相关。发现ER阳性与高核分级、低组织学分级、无肿瘤坏死、显著肿瘤弹性组织变性以及老年患者显著相关。所列举的这些病理参数直接或间接与肿瘤分化相关,提示ER代表了肿瘤分化的另一个指标。多变量分析显示年龄和肿瘤分化均与ER状态相关。在老年女性中,高分化肿瘤更常为ER阳性。纳入肿瘤坏死估计值以及患者年龄似乎有助于在低分化病变中进一步区分ER状态。关于ER和肿瘤分化的考量为绝经前和绝经后女性辅助化疗反应的二分法提供了一种可能的解释。